House KW - Search Results

1

Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.

Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM. Cowie RL, et al. Among authors: house kw. Clin Ther. 2007 Jul;29(7):1390-402. doi: 10.1016/j.clinthera.2007.07.021. Clin Ther. 2007. PMID: 17825690 Clinical Trial.

2

Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.

Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P. Nathan RA, et al. Clin Ther. 2006 Jan;28(1):73-85. doi: 10.1016/j.clinthera.2006.01.008. Clin Ther. 2006. PMID: 16490581 Clinical Trial.

3

The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma.

Malone R, LaForce C, Nimmagadda S, Schoaf L, House K, Ellsworth A, Dorinsky P. Malone R, et al. Ann Allergy Asthma Immunol. 2005 Jul;95(1):66-71. doi: 10.1016/S1081-1206(10)61190-8. Ann Allergy Asthma Immunol. 2005. PMID: 16095144 Clinical Trial.

4

Fluticasone propionate and salmeterol administered via Diskus compared with salmeterol or fluticasone propionate alone in patients suboptimally controlled with short-acting beta2-agonists.

Murray J, Rosenthal R, Somerville L, Blake K, House K, Baitinger L, VanderMeer A, Dorinsky P. Murray J, et al. Ann Allergy Asthma Immunol. 2004 Oct;93(4):351-9. doi: 10.1016/S1081-1206(10)61394-4. Ann Allergy Asthma Immunol. 2004. PMID: 15521371 Clinical Trial.

5

Efficacy and safety of fluticasone propionate/salmeterol HFA 134A MDI in patients with mild-to-moderate persistent asthma.

Pearlman DS, Peden D, Condemi JJ, Weinstein S, White M, Baitinger L, Scott C, Ho SY, House K, Dorinsky P. Pearlman DS, et al. J Asthma. 2004;41(8):797-806. doi: 10.1081/jas-200038368. J Asthma. 2004. PMID: 15641629 Clinical Trial.

6

Pharmacokinetic, pharmacodynamic, efficacy, and safety data from two randomized, double-blind studies in patients with asthma and an in vitro study comparing two dry-powder inhalers delivering a combination of salmeterol 50 microg and fluticasone propionate 250 microg: implications for establishing bioequivalence of inhaled products.

Daley-Yates PT, Parkins DA, Thomas MJ, Gillett B, House KW, Ortega HG. Daley-Yates PT, et al. Among authors: house kw. Clin Ther. 2009 Feb;31(2):370-85. doi: 10.1016/j.clinthera.2009.02.007. Clin Ther. 2009. PMID: 19302910

7

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: a randomized, double-blind, placebo-controlled trial.

Kavuru M, Melamed J, Gross G, Laforce C, House K, Prillaman B, Baitinger L, Woodring A, Shah T. Kavuru M, et al. J Allergy Clin Immunol. 2000 Jun;105(6 Pt 1):1108-16. doi: 10.1067/mai.2000.105711. J Allergy Clin Immunol. 2000. PMID: 10856143 Clinical Trial.

8

Combined salmeterol 50 microg and fluticasone propionate 250 microg in the diskus device for the treatment of asthma.

Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, Baitinger L, House K, Prillaman B, Shah T. Shapiro G, et al. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):527-34. doi: 10.1164/ajrccm.161.2.9905091. Am J Respir Crit Care Med. 2000. PMID: 10673196 Clinical Trial.

9

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.

Peden DB, Berger WE, Noonan MJ, Thomas MR, Hendricks VL, Hamedani AG, Mahajan P, House KW. Peden DB, et al. Among authors: house kw. J Allergy Clin Immunol. 1998 Jul;102(1):32-8. doi: 10.1016/s0091-6749(98)70052-1. J Allergy Clin Immunol. 1998. PMID: 9679845 Clinical Trial.

10

Once-daily fluticasone furoate is efficacious in patients with symptomatic asthma on low-dose inhaled corticosteroids.

Bleecker ER, Bateman ED, Busse WW, Woodcock A, Frith L, House KW, Jacques L, Davis AM, Haumann B, Lötvall J. Bleecker ER, et al. Among authors: house kw. Ann Allergy Asthma Immunol. 2012 Nov;109(5):353-358.e4. doi: 10.1016/j.anai.2012.08.017. Ann Allergy Asthma Immunol. 2012. PMID: 23062392 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters